Clinical Trial Update: Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma

View source ↗

Summary

This completed clinical trial update evaluates the prognostic potential of cell surface markers and Pim kinase expression in multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Medical University of South Carolina | Conditions: Multiple Myeloma | Status: COMPLETED